ArticleAntimicrobial agents and chemotherapy2024

Assessment of the activity and mechanisms of resistance to cefiderocol and combinations of β-lactams and the novel β-lactamase inhibitors avibactam, taniborbactam, zidebactam, nacubactam, xeruborbactam, and ANT3310 in emerging double-carbapenemase-producing Enterobacterales.

Tania Blanco-Martín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.